Ian M. H. Li

Ian M. H. Li

Auto-generated profile, based on publicly available information

Ian M. H. Li

Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ILIan M. H. Li
Ian M. H. Li
KLKe Liu
Ke Liu
ANAlice Neal
Alice Neal
PCPeter Clegg
Peter Clegg
SVSarah De Val
Sarah De Val
GBGeorge Bou-Gharios
George Bou-Gharios
The transcriptional mechanism through which chondrocytes control the spatial and temporal composition of the cartilage tissue has remained largely elusive. The central aim of this study was to identify whether transcriptional enhancers played a role in the organisation of the chondrocytes in cartilaginous tissue. We focused on the Aggrecan gene (Acan) as it is essential for the normal structure and function of cartilage and it is expressed developmentally in different stages of chondrocyte maturation. Using transgenic reporter studies in mice we identified four elements, two of which showed individual chondrocyte developmental stage specificity. In particular, one enhancer (−80) distinguishes itself from the others by being predominantly active in adult cartilage. Furthermore, the −62 element uniquely drove reporter activity in early chondrocytes. The remaining chondrocyte specific enhancers, +28 and −30, showed no preference to chondrocyte type. The transcription factor SOX9 interacted with all the enhancers in vitro and mutation of SOX9 binding sites in one of the enhancers (−30) resulted in a loss of its chondrocyte specificity and ectopic enhancer reporter activity. Thus, the Acan enhancers orchestrate the precise spatiotemporal expression of this gene in cartilage types at different stages of development and adulthood.

24 August 2017
Verified
Book Chapter
Closed access
PDF file
ILIan M. H. Li
Ian M. H. Li
AHAmy L. Horwell
Amy L. Horwell
GCGrace Chu
Grace Chu
BCBenoit de Crombrugghe
Benoit de Crombrugghe
GBGeorge Bou-Gharios
George Bou-Gharios

18 December 2017 in Journal of Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
SFStephanie L. Frost
Stephanie L. Frost
KLKe Liu
Ke Liu
ILIan M. H. Li
Ian M. H. Li
BPBlandine Poulet
Blandine Poulet
ECEithne Comerford
Eithne Comerford
GBGeorge Bou-Gharios
George Bou-Gharios
CCN2 is a critical matricellular protein that is expressed in several cells with major implications in physiology and different pathologies. However, the transcriptional regulation of this gene remains obscure. We used the Encyclopaedia of DNA Elements browser (ENCODE) to visualise the region spanning from 300 kb upstream to the CCN2 start site in silico in order to identify enhancer regions that regulate transcription of this gene. Selection was based on three criteria associated with enhancer regions: 1) H3K4me1 and H3K27ac histone modifications, 2) DNase I hypersensitivity of chromatin and 3) inter-species conservation. Reporter constructs were created with sequences spanning each of the regions of interest placed upstream of an Hsp68 silent proximal promoter sequence in order to drive the expression of β-galactosidase transgene. Each of these constructs was subsequently used to create transgenic mice in which reporter gene production was assessed at the E15.5 developmental stage. Four functional enhancers were identified, with each driving distinct, tissue-specific patterns of transgene expression. An enhancer located -100 kb from the CCN2 transcription start site facilitated expression within vascular tissue. An enhancer -135 kb upstream of CCN2 drove expression within the articular chondrocytes of synovial joints. The other two enhancers, located at -198 kb and -229 kb, mediated transgene expression within dermal fibroblasts, however the most prevalent activity was found within hypertrophic chondrocytes and periosteal tissue, respectively. These findings suggest that the global expression of CCN2 during development results from the activity of several tissue-specific enhancer regions in addition to proximal regulatory elements that have previously been demonstrated to drive transcription of the gene during development.

7 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YJYoungsook Lucy Jung
Youngsook Lucy Jung
WZWenping Zhao
Wenping Zhao
ILIan Li
Ian Li
DJDhawal Jain
Dhawal Jain
CECharles B. Epstein
Charles B. Epstein
MMMichael Mannstadt
Michael Mannstadt
In all terrestrial vertebrates, the parathyroid glands are critical regulators of calcium homeostasis and the sole source of parathyroid hormone (PTH). Hyperparathyroidism and hypoparathyroidism are clinically important disorders affecting multiple organs. However, our knowledge regarding regulatory mechanisms governing the parathyroids has remained limited. Here, we present the comprehensive maps of the chromatin landscape of the human parathyroid glands, identifying active regulatory elements and chromatin interactions. These data allow us to define regulatory circuits and previously unidentified genes that play crucial roles in parathyroid biology. We experimentally validate candidate parathyroid-specific enhancers and demonstrate their integration with GWAS SNPs for parathyroid-related diseases and traits. For instance, we observe reduced activity of a parathyroid-specific enhancer of the Calcium Sensing Receptor gene, which contains a risk allele associated with higher PTH levels compared to the wildtype allele. Our datasets provide a valuable resource for unraveling the mechanisms governing parathyroid gland regulation in health and disease.